Allen James Bailey, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alcoholism | 7 | 2023 | 1973 | 1.940 |
Why?
|
| Alcohol-Related Disorders | 2 | 2023 | 238 | 1.390 |
Why?
|
| Collagen | 13 | 2009 | 2638 | 1.300 |
Why?
|
| Substance-Related Disorders | 9 | 2024 | 4420 | 1.170 |
Why?
|
| Impulsive Behavior | 2 | 2022 | 346 | 0.790 |
Why?
|
| Psychopathology | 2 | 2021 | 432 | 0.730 |
Why?
|
| Osteoarthritis | 5 | 2007 | 1063 | 0.690 |
Why?
|
| Reward | 3 | 2021 | 971 | 0.580 |
Why?
|
| Alcohol Drinking | 6 | 2023 | 4028 | 0.550 |
Why?
|
| Behavior, Addictive | 1 | 2021 | 462 | 0.510 |
Why?
|
| Memory, Short-Term | 2 | 2023 | 982 | 0.510 |
Why?
|
| Bone and Bones | 5 | 2007 | 2568 | 0.490 |
Why?
|
| Intelligence | 1 | 2019 | 924 | 0.460 |
Why?
|
| Ligaments, Articular | 2 | 2006 | 302 | 0.410 |
Why?
|
| Anterior Cruciate Ligament | 2 | 2005 | 423 | 0.380 |
Why?
|
| Borderline Personality Disorder | 1 | 2019 | 768 | 0.380 |
Why?
|
| Decision Making | 2 | 2022 | 3929 | 0.360 |
Why?
|
| Guinea Pigs | 6 | 2008 | 1310 | 0.340 |
Why?
|
| Schizotypal Personality Disorder | 2 | 2021 | 290 | 0.330 |
Why?
|
| Severity of Illness Index | 3 | 2023 | 15843 | 0.320 |
Why?
|
| Antisocial Personality Disorder | 2 | 2020 | 224 | 0.320 |
Why?
|
| Factor Analysis, Statistical | 2 | 2023 | 999 | 0.310 |
Why?
|
| Fibrillar Collagens | 1 | 2008 | 42 | 0.300 |
Why?
|
| Oligopeptides | 2 | 2004 | 1187 | 0.300 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 2897 | 0.300 |
Why?
|
| Hallucinogens | 2 | 2022 | 197 | 0.280 |
Why?
|
| Depressive Disorder | 1 | 2020 | 3728 | 0.280 |
Why?
|
| Collagen Type I | 3 | 2005 | 616 | 0.260 |
Why?
|
| Leg Bones | 1 | 2005 | 19 | 0.250 |
Why?
|
| Stifle | 1 | 2004 | 28 | 0.240 |
Why?
|
| Calorimetry, Differential Scanning | 4 | 2004 | 100 | 0.220 |
Why?
|
| Health Surveys | 2 | 2024 | 4061 | 0.220 |
Why?
|
| Protein Denaturation | 4 | 2004 | 242 | 0.220 |
Why?
|
| Malondialdehyde | 1 | 2003 | 112 | 0.220 |
Why?
|
| Psychotic Disorders | 3 | 2024 | 3223 | 0.220 |
Why?
|
| Young Adult | 11 | 2024 | 59260 | 0.220 |
Why?
|
| Arthritis, Experimental | 1 | 2006 | 291 | 0.220 |
Why?
|
| Tendons | 2 | 2004 | 558 | 0.210 |
Why?
|
| Serum Albumin, Bovine | 1 | 2003 | 321 | 0.210 |
Why?
|
| Histidine | 1 | 2003 | 308 | 0.210 |
Why?
|
| Tranquilizing Agents | 1 | 2022 | 58 | 0.210 |
Why?
|
| Dogs | 2 | 2005 | 3839 | 0.210 |
Why?
|
| Hindlimb | 1 | 2005 | 513 | 0.210 |
Why?
|
| Marijuana Abuse | 2 | 2024 | 411 | 0.200 |
Why?
|
| Osteoblasts | 3 | 2007 | 1143 | 0.190 |
Why?
|
| Biomimetic Materials | 1 | 2003 | 172 | 0.190 |
Why?
|
| Delusions | 1 | 2023 | 298 | 0.190 |
Why?
|
| Temperature | 2 | 2004 | 2226 | 0.180 |
Why?
|
| Protein Structure, Quaternary | 1 | 2002 | 429 | 0.180 |
Why?
|
| Procollagen | 3 | 2005 | 187 | 0.170 |
Why?
|
| Mental Disorders | 1 | 2020 | 6845 | 0.170 |
Why?
|
| Bone Remodeling | 1 | 2004 | 581 | 0.170 |
Why?
|
| Cartilage | 1 | 2004 | 806 | 0.170 |
Why?
|
| Femur | 1 | 2005 | 1307 | 0.160 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2009 | 1541 | 0.160 |
Why?
|
| Syndrome | 2 | 2022 | 3267 | 0.160 |
Why?
|
| Matrix Metalloproteinase 2 | 3 | 2005 | 459 | 0.160 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2022 | 1988 | 0.150 |
Why?
|
| Analgesics, Opioid | 4 | 2023 | 3808 | 0.150 |
Why?
|
| Cross-Linking Reagents | 3 | 2005 | 687 | 0.140 |
Why?
|
| Hydrolysis | 2 | 2009 | 664 | 0.140 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2022 | 625 | 0.140 |
Why?
|
| Adolescent | 7 | 2024 | 88326 | 0.140 |
Why?
|
| Humans | 31 | 2024 | 761596 | 0.140 |
Why?
|
| Cannabis | 1 | 2022 | 441 | 0.130 |
Why?
|
| Knee Joint | 1 | 2005 | 1676 | 0.130 |
Why?
|
| Heroin | 1 | 2016 | 119 | 0.130 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 2 | 2005 | 72 | 0.120 |
Why?
|
| Osteoarthritis, Knee | 1 | 2005 | 1234 | 0.120 |
Why?
|
| Personality Disorders | 1 | 2019 | 722 | 0.120 |
Why?
|
| Peptides | 2 | 2003 | 4358 | 0.120 |
Why?
|
| Paranoid Disorders | 2 | 2024 | 61 | 0.110 |
Why?
|
| Lysine | 3 | 2008 | 993 | 0.100 |
Why?
|
| Arginine | 2 | 2008 | 934 | 0.100 |
Why?
|
| Male | 13 | 2024 | 360846 | 0.100 |
Why?
|
| Glycosaminoglycans | 2 | 2005 | 607 | 0.100 |
Why?
|
| Adult | 8 | 2024 | 221210 | 0.100 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2005 | 632 | 0.090 |
Why?
|
| Central Nervous System Stimulants | 1 | 2019 | 1177 | 0.090 |
Why?
|
| Female | 13 | 2024 | 392705 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2008 | 3769 | 0.090 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2009 | 201 | 0.080 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2009 | 297 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2006 | 18255 | 0.080 |
Why?
|
| Anxiety Disorders | 1 | 2020 | 2720 | 0.080 |
Why?
|
| Borohydrides | 1 | 2008 | 32 | 0.080 |
Why?
|
| Buffers | 1 | 2008 | 146 | 0.080 |
Why?
|
| Hydroxyproline | 2 | 2004 | 110 | 0.070 |
Why?
|
| Personality | 2 | 2021 | 554 | 0.070 |
Why?
|
| United States | 3 | 2024 | 72340 | 0.070 |
Why?
|
| Animals | 13 | 2008 | 168475 | 0.070 |
Why?
|
| Glucose | 2 | 2009 | 4347 | 0.070 |
Why?
|
| Ethanol | 2 | 2023 | 1324 | 0.070 |
Why?
|
| Prevalence | 1 | 2023 | 15733 | 0.070 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 26129 | 0.060 |
Why?
|
| Carbohydrates | 1 | 2008 | 390 | 0.060 |
Why?
|
| Cognition | 1 | 2023 | 6992 | 0.060 |
Why?
|
| Elastin | 2 | 2003 | 298 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2020 | 9319 | 0.060 |
Why?
|
| Glycosylation | 1 | 2008 | 1097 | 0.060 |
Why?
|
| Neuropsychological Tests | 1 | 2018 | 7054 | 0.060 |
Why?
|
| Chorionic Gonadotropin | 1 | 2007 | 457 | 0.060 |
Why?
|
| Calorimetry | 1 | 2004 | 129 | 0.060 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2004 | 97 | 0.060 |
Why?
|
| Luteinizing Hormone | 1 | 2007 | 820 | 0.060 |
Why?
|
| Oxidation-Reduction | 2 | 2008 | 2231 | 0.060 |
Why?
|
| Comorbidity | 1 | 2019 | 10508 | 0.060 |
Why?
|
| Rupture, Spontaneous | 1 | 2005 | 362 | 0.060 |
Why?
|
| Epiphyses | 1 | 2005 | 190 | 0.060 |
Why?
|
| Metalloproteases | 1 | 2004 | 61 | 0.060 |
Why?
|
| Thermodynamics | 1 | 2004 | 595 | 0.050 |
Why?
|
| Hydroxylysine | 1 | 2002 | 4 | 0.050 |
Why?
|
| Hydrogen Bonding | 1 | 2003 | 291 | 0.050 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2002 | 55 | 0.050 |
Why?
|
| Peptide Fragments | 2 | 2005 | 5112 | 0.050 |
Why?
|
| X-Ray Diffraction | 1 | 2003 | 421 | 0.050 |
Why?
|
| Pyrroles | 1 | 2009 | 1125 | 0.050 |
Why?
|
| Collagen Type III | 1 | 2002 | 91 | 0.050 |
Why?
|
| Tail | 1 | 2002 | 91 | 0.050 |
Why?
|
| Risk Factors | 2 | 2019 | 74213 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 1741 | 0.050 |
Why?
|
| Rats | 3 | 2008 | 23741 | 0.050 |
Why?
|
| Amino Acids | 1 | 2008 | 1718 | 0.050 |
Why?
|
| Femur Head | 1 | 2004 | 297 | 0.050 |
Why?
|
| Twins | 1 | 2023 | 339 | 0.050 |
Why?
|
| Skin | 2 | 2008 | 4484 | 0.050 |
Why?
|
| Bone Density | 2 | 2006 | 3551 | 0.050 |
Why?
|
| Opioid-Related Disorders | 1 | 2016 | 2164 | 0.050 |
Why?
|
| Schizophrenia | 1 | 2020 | 6937 | 0.050 |
Why?
|
| Diaphragm | 1 | 2002 | 351 | 0.050 |
Why?
|
| Protein Structure, Secondary | 1 | 2004 | 1229 | 0.050 |
Why?
|
| Cocaine-Related Disorders | 1 | 2024 | 461 | 0.050 |
Why?
|
| Prognosis | 1 | 2020 | 29629 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2002 | 1749 | 0.040 |
Why?
|
| Avoidance Learning | 1 | 2020 | 248 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2002 | 943 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2006 | 1787 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2004 | 2850 | 0.040 |
Why?
|
| Water | 1 | 2004 | 1411 | 0.040 |
Why?
|
| Time Factors | 1 | 2020 | 39969 | 0.040 |
Why?
|
| Joint Instability | 1 | 2006 | 801 | 0.040 |
Why?
|
| Nucleus Accumbens | 1 | 2020 | 366 | 0.040 |
Why?
|
| Cattle | 1 | 2003 | 3849 | 0.040 |
Why?
|
| Self Report | 2 | 2021 | 3725 | 0.040 |
Why?
|
| Hot Temperature | 1 | 2004 | 1440 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 3810 | 0.040 |
Why?
|
| Blood Vessels | 1 | 2002 | 1113 | 0.030 |
Why?
|
| Personality Inventory | 1 | 2020 | 1019 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2004 | 1726 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2003 | 2192 | 0.030 |
Why?
|
| Middle Aged | 4 | 2024 | 220921 | 0.030 |
Why?
|
| Heroin Dependence | 1 | 2016 | 172 | 0.030 |
Why?
|
| Kinetics | 1 | 2003 | 6374 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2003 | 1685 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2003 | 3968 | 0.030 |
Why?
|
| Binding Sites | 1 | 2003 | 6056 | 0.030 |
Why?
|
| Hypnotics and Sedatives | 1 | 2022 | 1179 | 0.030 |
Why?
|
| Social Class | 1 | 2023 | 2004 | 0.030 |
Why?
|
| Gyrus Cinguli | 1 | 2020 | 1115 | 0.030 |
Why?
|
| Psychometrics | 1 | 2024 | 3065 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 6534 | 0.030 |
Why?
|
| Aged | 2 | 2023 | 169310 | 0.030 |
Why?
|
| Radiography | 1 | 2005 | 6965 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2024 | 2639 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2020 | 64685 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2003 | 5439 | 0.030 |
Why?
|
| Executive Function | 1 | 2020 | 1392 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 13446 | 0.020 |
Why?
|
| Motivation | 1 | 2020 | 2006 | 0.020 |
Why?
|
| Protein Binding | 1 | 2003 | 9353 | 0.020 |
Why?
|
| Attention | 1 | 2020 | 2396 | 0.020 |
Why?
|
| Sex Factors | 1 | 2024 | 10554 | 0.020 |
Why?
|
| Prefrontal Cortex | 1 | 2020 | 2220 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 2003 | 2561 | 0.020 |
Why?
|
| Disease Progression | 1 | 2006 | 13510 | 0.020 |
Why?
|
| Receptors, LH | 1 | 2007 | 18 | 0.020 |
Why?
|
| Parents | 1 | 2020 | 3563 | 0.020 |
Why?
|
| Goserelin | 1 | 2007 | 126 | 0.020 |
Why?
|
| Calcitriol | 1 | 2007 | 296 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2003 | 5841 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2007 | 614 | 0.010 |
Why?
|
| Deamination | 1 | 2003 | 25 | 0.010 |
Why?
|
| Phenotype | 1 | 2002 | 16592 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2005 | 1141 | 0.010 |
Why?
|
| Desmosine | 1 | 2002 | 19 | 0.010 |
Why?
|
| Bone Resorption | 1 | 2007 | 723 | 0.010 |
Why?
|
| Cell Count | 1 | 2007 | 1835 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2007 | 1757 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2002 | 777 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2002 | 1545 | 0.010 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2007 | 1148 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2007 | 6131 | 0.010 |
Why?
|
| Mice | 2 | 2002 | 81539 | 0.010 |
Why?
|
| Homozygote | 1 | 2002 | 1776 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2002 | 58984 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 8181 | 0.010 |
Why?
|
| Aorta | 1 | 2002 | 2041 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 36426 | 0.010 |
Why?
|
| Alleles | 1 | 2002 | 6864 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2002 | 9542 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 14665 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2007 | 11530 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2005 | 9177 | 0.000 |
Why?
|
| Lung | 1 | 2002 | 10002 | 0.000 |
Why?
|
| Mutation | 1 | 2002 | 30053 | 0.000 |
Why?
|